13 January 2017
MS in the media logo (a pile of newspapers)
  • Mixed results for cyclophosphamide in SPMS
  • MS on TV
  • Paleo diet trial results
  • Review of evidence for cannabis
  • Review of research in 2016
Read more

06 January 2017
MS in the media logo (a pile of newspapers)
  • New Year's honours for people with MS
  • Lifestyle impact on MS
  • Living near busy roads
  • Magnetic stimulation and brain activity
  • Gilenya (fingolimod) in Wales
Read more

23 December 2016
MS in the media logo (a pile of newspapers)
  • Falls and bladder problems
  • The World vs MS
  • Tysabri concentrations and PML
  • Ocrelizumab trial results published
  • Breath test for diagnosis
Read more

09 December 2016
MS in the media logo (a pile of newspapers)
  • Copaxone and pregnancy recommendations changed
  • Racing driver with MS
  • Disease modifying treatment in more advanced stage MS
Read more

02 December 2016
MS in the media logo (a pile of newspapers)
  • Sports Personality of the Year shortlist published
  • Vitamin D and MS risk
  • What stem cell research says about progressive MS
  • Researching diet and MS
  • Emerging treatments for progressive MS
Read more

18 November 2016
MS in the media logo (a pile of newspapers)
  • Course of later onset MS
  • Effect of fatigue and depression on sex
  • Ballet for ataxia
Read more

11 November 2016
MS in the media logo (pile of newspapers)
  • Use of dietary approaches to manage MS
  • Brain tissue ratios and prognosis
  • Exercise is valuable for people with more advanced MS
  • Development of progressive MS research
Read more

04 November 2016
MS in the media logo
  • Work capability assessment to be reviewed
  • Rituximab
  • MS and breast cancer
  • Fampridine
  • Living up north could speed up onset of MS
Read more

28 October 2016
MS in the media logo (a pile of newspapers)
  • ECTRIMS video highlights
  • MS in the modern treatment era
  • Biotin study results
  • Nerves that affect postural control
Read more

21 October 2016
MS in the media
  • SNP backs decriminalising cannabis for medical use
  • More MS nurses needed in West Yorkshire
  • Tysabri (natalizumab) reduces depression in MS
  • MS Society survey finds "disturbing levels" of workplace bullying
  • Importance of family
Read more

14 October 2016
MS in the media logo (pile of newspapers)
  • How people with MS feel about risk
  • Stress and onset of symptoms
  • Lemtrada (alemtuzumab) and disability improvement
  • Stress incontinence in women with MS
  • Factors indicating how MS may develop
  • Low dose naltrexone safety study
  • Intimate relations
Read more

07 October 2016
MS in the media logo (a pile of newspapers)
  • ESA re-assessments
  • NICE turns down daclizumab
  • Mindfulness helps with coping
  • Tysabri vs Gilenya comparison
Read more

23 September 2016
ECTRIMS 2016 - picture of Tower Bridge in London

Reports of studies presented at the ECTRIMS meeting that took place from 14-17 September 2016.  Reports include research into disease modifying drugs for relapsing and progressive MS, stem cells and lifestyle factors in MS.

Read more

23 September 2016
MS in the media logo (a pile of newspapers)
  • MS at the Paralympics
  • Gene research for progressive MS questioned
  • Natural history of people on disease modifying drugs
  • MPs support call for medical cannabis
  • Film about footballer with MS released on DVD
  • Older people with MS
  • Ageing with MS
  • Progressive MS research funding
  • Guidelines on more than one long-term condition
  • ECTRIMS round up
Read more

09 September 2016
MS in the media logo (pile of newspapers)
  • How heat affects people with MS
  • Paralympians with MS
  • Negative attitudes to people with MS
  • Tamoxifen may help myelin repair
  • Genes don't suggest course of MS
Read more

02 September 2016
MS in the media logo (pile of newspapers)
  • The effect of childhood MS on parents
  • Review of the medical understanding of childhood MS
  • Explaining MS
  • Please offer me a seat
  • How lifestyle factors affect MS
  • Photography project focuses on MS
  • Low white blood cell count and MS
Read more

26 August 2016
MS in the media logo (pile of newspapers)
  • Genes and vitamin D
  • Siponimod trial in secondary progressive MS
  • Amiselimod trial results
Read more

19 August 2016
MS in the media logo (pile of newspapers)
  • Wales lagging behind in access to treatment
  • High blood pressure may be associated with MS progression
  • Neurological Alliance report on neurology and primary care
  • Benefits changes and eligibility for Motability
  • Camping with MS
Read more

12 August 2016
MS in the media logo
  • Using mobility scooter for days out
  • New technique for stem cell transplants
  • Benefits of early treatment
Read more

05 August 2016
MS in the media logo (pile of newspapers)
  • Gut microbes and MS
  • Financial, personal and work related impact of MS
  • Relapses following second or subsequent pregnancies
  • TENS for MS spasticity
  • Poetry and MS
  • Assistance dog
  • Coping with life's changes
Read more

29 July 2016
MS in the media logo (pile of newspapers)
  • Disease modifying drugs may help people with "benign" MS
  • Stephanie Millward talks about the impact of MS
  • Stem cells
  • Anecdotal success and research evidence
  • Financial management with MS
  • Communicating prognosis
  • Disabled dressage rider asked to pay extra for using additional equipment
  • Study highlights progressive decline for people with MS

 

Read more

22 July 2016
MS in the media logo (pile of newspapers)
  • Developing drugs for progressive MS
  • Magician on living with MS
  • Vitamin D recommendation for general population
Read more

08 July 2016
MS in the media logo
  • Overweight people more likely to develop MS
  • Gut bacteria differ in people with MS
  • Integrated care transforms lives of disabled people
  • Lifestyle based approach to MS
  • Zinbryta (daclizumab) licensed
  • Effect of MS on carers
  • Cause of depression as MS symptom
Read more

24 June 2016
  • Commissioning community services
  • Progressive MS Alliance meeting
  • New genes associated with MS
  • Caroline Wyatt on her diagnosis
  • Rituximab
Read more

17 June 2016
  • Awareness of MS
  • Sleep and cognition
  • People affected by MS - Caroline Wyatt
  • People affected by MS - Stephanie Millward
  • Cerebral microbleeds
  • Vitamin D
Read more

10 June 2016
Pile of newspapers MS in the media
  • Older people with MS
  • Opicinumab (anti-lingo-1) trail disappointing
  • Stem cell trial shows long-term benefits
Read more

07 June 2016
Consortium of Multiple Sclerosis Centers MS in the media

Reports of studies presented at the CMSC (Consortium of Multiple Sclerosis Centers) meeting that took place from 1-4 June 2016.  Reports include research into  drugs for MS, better understanding of symptoms and lifestyle factors.

Read more

03 June 2016
newspapers MS in the media
  • Fasting-mimicking diet studied
  • More proactive care for sexual dysfunction encouraged
  • Golfer with MS
  • Gene linked to rare form of MS
Read more

27 May 2016
newspapers MS in the media
  • Vitamin D in Orkney
  • The effect of MS on employment
  • Invisible symptoms of MS
  • Young carers blog
  • Fasting-mimicking diet
  • A bicycle with MS
Read more

20 May 2016
Newspapers MS in the media
  • Neurological Alliance unhappy with government response to report
  • Relapses and disease modifying drugs
  • Progressive MS treatments review
  • Vitamin D levels in Orkney
  • Gut bacteria in children with MS
  • Viruses and onset of MS
  • Pregabalin and birth defects
  • Inequalities in multiple sclerosis care
  • Potential treatment for PML
Read more

13 May 2016
newspapers MS in the media
  • Long-term use of disease modifying drugs
  • Symptoms during relapses and progression
  • The potential of ocrelizumab
  • AAN meeting round up
  • Diet and inflammation in the brain
  • Cancer risk and MS
  • Mitoxantrone and cancer risk
  • Carers and the Care Act
  • Palliative care services patchy
Read more

06 May 2016
newspapers MS in the media
  • Zinbryta (daclizumab) nears approval in Europe
  • Ocrelizumab and progressive MS
  • Too much sitting is bad for you
  • Yoga or aquatic exercise help MS symptoms
  • CCSVI symptoms not unique to MS
  • Gilenya (fingolimod) rebound risk
  • Suicide rates higher in MS
Read more

29 April 2016
newspapers MS in the media
  • Engaging with MS services
  • Vitamin D review
  • Tysabri and progression study
  • Review of current research
  • Monitoring MS with mobile devices
  • MS affects moral cognition
Read more

22 April 2016
American Academy of Neurology (AAN)

Reports of studies presented at the American Academy of Neurology meeting that took place from 15-21 April 2016.  Reports include researchinto disease modifying drugs for relapsing MS, approaches to repair of nerves and risk factors for MS.

Read more

15 April 2016
newspapers MS in the media
  • Medical cannabis arguments
  • MS Therapy Centre visit
  • The interaction of pain, depression and fatigue
  • MS. A song cycle
  • Small trial hints at possibility of nerve repair
  • Identifying factors that increase MS risk
  • Footballer with MS
  • Punching sharks on the nose
Read more

08 April 2016
newspapers ms in the media
  • DMDs and brain atrophy
  • Do Paralympians encourage or deter exercise?
  • Beta interferon in children
  • Myelitis and MS
  • Most PIP appeals are successful
  • Switching to rituximab or Gilenya from Tysabri
  • The effect of other health conditions
Read more

01 April 2016
Newspapers MS in the media
  • Rosacea and MS risk
  • Finding new life in wheelchair tennis
  • Holidaymakers needed
  • MS in families studied
  • Finding positives
Read more

24 March 2016
newspapers MS in the media
  • World Congress on Controversies in Neurology (CONy)
  • Benefit changes withdrawn
  • Gadolinium safety review
  • Ibudilast fast track status
Read more

18 March 2016
newspapers MS in the media
  • The Budget and benefit changes
  • Beta interferon and pregnancy
  • Review of ACTRIMS neurology conference
  • MS in East London
Read more

11 March 2016
newspapers MS in the media
  • Vitamin D in pregnancy
  • More than one autoimmune condition and progression risk
  • Small study of antidiabetic drugs
  • Brain training may improve thinking
  • Athlete with MS
  • MS and other health conditions

 

Read more

04 March 2016
newspapers MS in the media
  • Recommendations for Tysabri and PML
  • Neurological services in Scotland
  • Pregnancy and risk of progression
  • Virtual reality and balance
  • Rituximab trial unsuccessful for SPMS
  • Coffee and risk of MS
Read more

26 February 2016
newspapers MS in the media
  • Rowing from home
  • Delays in MS services
  • Lessons for fingolimod for progressive MS trial
  • Neurological services criticised
  • Medicinal cannabis campaign
Read more

19 February 2016
newspapers MS in the media
  • EMA guidance on PML
  • Ocrelizumab approval process in the US
  • Ozanimod trial results
  • Disease modifying drugs and progression
  • Investigating the effect of other conditions on MS
Read more

12 February 2016
newspapers MS in the media
  • Vitamin D and onset of MS
  • Measuring disease activity
  • Gender differences in MS
  • Trial to predict how MS will develop
  • Woman with MS on bed blocking
  • Sense of taste
  • Smoking and nicotine
  • Christian Jessen's MS connection
  • Campaign launched to legalise medicinal cannabis
Read more

05 February 2016
newspapers MS in the media
  • Fingolimod for PPMS trial unsuccessful
  • Arthritis treatment and MS risk
  • The difficulty of claiming benefits
  • Step training study
  • Company pulls out of female hormone treatment
  • Work and MS
  • Tysabri v fingolimod
  • Indicators of risk of primary progressive MS
Read more

29 January 2016
newspapers MS in the media
  • Phenytoin trial results
  • Risk of relapse when switching treatment
  • Stem cell therapy review
  • Tysabri and risk of PML
  • Young carer
Read more

22 January 2016
newspapers MS in the media
  • Stem cells therapy on Panorama
  • Respite services in Edinburgh
  • The potential of stem cells
  • Oestrogen supplement trial results
  • Consultation on further changes to benefits
Read more

31 December 2015
newspapers MS in the media
  • NHS choir
  • Fampridine and walking speed
  • Work and MS symptoms
  • Talking to children about MS
  • Vitamin D study
Read more

24 December 2015
newspapers MS in the media
  • Success rate in MS drug trials
  • Review of the year
  • Biggest 'game changer' of 2015
  • Care home ratings
  • Stem cell therapy
Read more

18 December 2015
newspapers MS in the media
  • Brain cell death and nanoparticles
  • Making the most of your life with MS in 2016 and beyond
  • Sense of smell
  • Woman dies after ruling to stop feeding
Read more

11 December 2015
newspapers MS in the media
  • Vitamin D and myelin production
  • Rehabilitation research reviewed
  • John Kurtzke
  • National MS Society review of research 2015
Read more

04 December 2015
newspapers MS in the media
  • Songs about MS
  • Oestrogen supplement trial results
  • Biotin and optic neuritis
  • Coping with Christmas
  • Disability and society
Read more

26 November 2015
newspapers MS in the media
  • Social care crisis
  • Artists with MS
  • Spending Review
  • Reporting medically unfit drivers
Read more

20 November 2015
newspapers MS in the media
  • Tecfidera and PML
  • Chocolate and fatigue
  • The impact of benefit changes
  • End of life judgement
Read more

13 November 2015
  • Drug repurposing bill runs out of time
  • Diet and MS - Association of UK Dietitians policy statement
  • Vitamin D and atrophy
  • Cancer drug fund in Wales
Read more

30 October 2015

24-30 October 2015

  • EMA guidance on Tecfidera
  • People affected by MS - Dave Myers
  • Photographs of MS
  • HIV drug for MS
  • Accurately measuring fitness
  • Drug repurposing bill
Read more

23 October 2015
Pile of newspapers
  • Tysabri trial for SPMS is negative
  • ECTRIMS round up
  • The cost of MS
  • Athlete with MS
Read more

15 October 2015
  • ECTRIMS reports
  • Aubagio and brain tissue loss
  • Generic version of glatiramer acetate is effective
Read more

09 October 2015
  • Ocrelizumab effective in all types of MS
  • Daclizumab study results
  • Gilenya (fingolimod) long-term benefits
  • Aubagio (teriflunomide) real world study
  • Sativex in clinical practice
  • Stopping smoking reduces brain atrophy
  • Suicide and self harm risks higher in MS
Read more

08 October 2015
  • Tecfidera (dimethyl fumarate) follow up
  • Lemtrada (alemtuzumab) five year follow up
  • Tysabri (natalizumab) longer dosing
  • Gilenya (fingolimod) shows no benefit in primary progressive MS
  • Vitamin D levels and race
  • Sun exposure and low weight delay MS onset
  • Stem cell communication
Read more

07 October 2015
  • Woman of the Year award for woman with MS
  • Aubagio and atrophy
  • New MS centre in Stoke
Read more

30 September 2015
  • Early treatment urged for relapsing MS
  • Dalfampridine for vision
  • Living with MS
  • Athlete with MS
Read more

25 September 2015
  • Olympic hopeful with MS
  • Potential PML vaccine being developed
  • Measuring progression in trials
Read more

23 September 2015
  • NICE social care guidelines published
  • New progressive MS research grants
  • Disease modifying drugs review
  • What affects quality of life in MS?
Read more